Fuda Cancer Hospital
Fuda Cancer Hospital
China, Cantão
| China | Turki | Austria | |
| Tomoterapi | dari $17,500 | dari $12,000 | dari $30,000 |
| Sistem Robotik Da Vinci | dari $24,500 | dari $9,500 | dari $22,000 |
| Reseksi rektum | dari $18,200 | dari $10,250 | dari $21,000 |
| Pengangkatan polip lambung | dari $1,800 | dari $990 | dari $5,000 |
| NanoKnife | dari $22,500 | dari $9,500 | dari $25,000 |
Bookimed tidak menambah biaya tambahan dalam harga perawatan Kanker rektum. Tarif berasal dari daftar harga resmi klinik. Anda membayar langsung di klinik saat tiba di negara tujuan untuk perawatan Anda.
Bookimed berkomitmen pada keselamatan Anda. Kami hanya bekerja dengan institusi medis yang menjaga standar internasional tinggi dalam perawatan Kanker rektum dan memiliki izin yang dibutuhkan untuk melayani pasien internasional di seluruh dunia.
Bookimed menawarkan bantuan ahli gratis. Koordinator medis pribadi mendukung Anda sebelum, selama, dan setelah perawatan, menyelesaikan semua masalah Anda. Anda tidak pernah sendirian dalam perjalanan perawatan Kanker rektum Anda.
Professor Liang Xiaoxiao is the Department Director and Chief Physician in Neurorehabilitation. She holds a master’s degree in neurology. She is skilled in neuromodulation for disorders of consciousness, cognition, and movement. Her focus includes cases from cerebrovascular disease, Parkinson’s disease, and related conditions. She also performs ultrasound-guided botulinum toxin injections for blepharospasm, hemifacial spasm, limb spasticity, sialorrhea, and neuralgia.
Accreditations and roles: Member of the Neurorehabilitation, Cognitive Disorder Rehabilitation, and Craniocerebral Trauma Rehabilitation Committees of the Chinese Association of Rehabilitation Medicine. Standing Member of the Cognitive Disorder Rehabilitation Committee of the Fujian Association of Rehabilitation Medicine. Vice Chair of the Dementia and Cognitive Disorder Committee of the Xiamen Preventive Medicine Association. Vice President of the Parkinson’s Disease and Movement Disorders Committee of the Xiamen Medical Doctor Association. Standing Member of the Neuromodulation Committee of the Xiamen Medical Doctor Association. Recipient of the Most Beautiful Physician of Xiamen City (2024).
Dr. Liu Shi Xin is the Vice Chairman of the Radiation Oncology Branch of the Chinese Medical Association. He serves as the Discipline Leader of the Oncology Center at Xiamen Humanity Hospital. Dr. Liu specializes in precision radiotherapy for thoracic and abdominal cancers. He is a recipient of the State Council Special Government Allowance for his medical contributions.
Professor Zheng Qiu Hong is Director of the Cell Therapy Research Center and a National Senior Expert in Biotherapy. He is a Professor and Master’s Supervisor at Fujian Medical University. He has more than 30 years of clinical experience in tumor molecular biology and biotherapy. From 2012 to 2013, he was a visiting scholar in stem cell research at the University of Connecticut School of Life Sciences. He previously held leadership roles at Fujian Cancer Hospital. These roles included Director of the Tumor Molecular Biology Laboratory and Director of the Surgical Oncology Research Laboratory. He also served as Deputy Director of the Fujian Key Laboratory of Tumor Biotherapy and Deputy Director of the Biotherapy and Immunotherapy Center.
Appointments include Standing Committee Member of the Biotherapy Committee of the Chinese Research Hospital Association. He is also a Committee Member of the Tumor Immunology and Biotherapy Committee of the Chinese Society for Immunology. In addition, he is Deputy Chair of the Academic Committee of the Xiamen Cell Therapy Research Center at the First Affiliated Hospital of Xiamen University.
Di Tiongkok, pengobatan kanker rektum berfokus pada eksisi mesorektal total (TME) dan operasi minimal invasif. Rumah sakit kanker terkemuka di Guangzhou dan Shanghai menggunakan sistem robotik da Vinci. Pusat-pusat khusus yang terakreditasi JCI mengintegrasikan krioterapi, NanoKnife, dan imunoterapi untuk mengobati kasus-kasus stadium lanjut.
Pendapat para ahli Bookimed: Data pasien menunjukkan preferensi terhadap pusat-pusat di Guangzhou karena keahlian mereka dalam pengobatan alternatif. Rumah Sakit Kanker Fuda telah merawat lebih dari 30.000 pasien internasional. Mereka mengkhususkan diri dalam menggabungkan teknik invasif minimal, seperti NanoKnife, dengan protokol onkologi standar. Pendekatan ini menawarkan pilihan dalam kasus-kasus di mana pembedahan tradisional bukanlah pilihan pengobatan utama.
Opini pasien: Pasien menekankan pentingnya pengujian genetik tumor sejak dini, seperti MSI dan KRAS, untuk mengakses obat-obatan yang ditargetkan. Banyak yang mencatat bahwa pengobatan di Tiongkok dimulai jauh lebih cepat daripada di negara-negara Barat.
Di Tiongkok, pasien kanker rektum dapat menghindari kolostomi permanen berkat operasi modern yang mempertahankan sfingter, seperti reseksi intersfingter (ISR). Pusat-pusat besar melaporkan keberhasilan preservasi anus pada 75% kasus kanker rektum usus bagian bawah. Teknik seperti terapi neoadjuvan mengurangi ukuran tumor, memungkinkan pengangkatan yang lebih aman sambil mempertahankan fungsi usus normal.
Opini ahli Bookimed: Data klinis menunjukkan bahwa institusi medis terakreditasi JCI seperti Rumah Sakit Kanker Fuda menggunakan lebih dari 10 jenis perawatan invasif minimal. Pasien sering mengabaikan fakta bahwa, meskipun pembedahan adalah prosedur standar, menggabungkannya dengan perawatan lokal seperti krioterapi atau nanoknife dapat meningkatkan margin reseksi. Pendekatan multimodal ini sangat membantu dalam menjaga sfingter pada tumor yang terletak sangat dekat dengan anus.
Pendapat pasien: Pasien menekankan pentingnya mendapatkan pendapat kedua di rumah sakit terkemuka untuk menghindari kolostomi tergesa-gesa dan permanen yang direkomendasikan oleh klinik lokal. Mereka mencatat bahwa meskipun ileostomi mungkin diperlukan, biasanya bersifat sementara, berlangsung selama 6 hingga 16 minggu untuk penyembuhan.
Bedah robotik untuk kanker rektum tersedia secara luas di rumah sakit umum terkemuka di Tiongkok. Hingga tahun 2020, bedah ini mencakup hampir 49% dari semua operasi rektum. Pusat-pusat utama di Guangzhou, Shanghai, dan Beijing menggunakan sistem da Vinci, serta platform domestik seperti MicroPort Toumai, untuk mengangkat tumor secara presisi.
Opini ahli Bookimed: Meskipun pusat-pusat elit seperti Rumah Sakit Kanker Fuda mengkhususkan diri dalam krioterapi minimal invasif dan nanoknife, platform robotik terkonsentrasi di rumah sakit akademik besar. Data menunjukkan bahwa ribuan operasi dilakukan di pusat-pusat tersier ini, yang menegaskan tingkat keahlian bedah yang tinggi dalam reseksi panggul yang kompleks.
Opini pasien: Pasien mencatat bahwa operasi robotik secara signifikan mengurangi lama rawat inap dibandingkan dengan operasi terbuka. Banyak yang menekankan bahwa akses ke teknologi ini membutuhkan perjalanan ke kota-kota besar seperti Guangzhou.
Di Tiongkok, pasien kanker rektum memiliki akses ke obat imunoterapi inovatif seperti sintilimab, toripalimab, dan pembrolizumab. Agen target terkemuka meliputi fruquintinib dan cetuximab. Obat-obatan ini menargetkan penanda molekuler spesifik seperti MSI-H/dMMR atau RAS tipe liar. Institusi seperti Rumah Sakit Kanker Fuda menawarkan perawatan minimal invasif mutakhir di samping agen farmakologis ini.
Opini ahli Bookimed: Meskipun obat-obatan seperti pembrolizumab tersedia secara global, inovasi lokal seperti fruquintinib menawarkan keuntungan yang signifikan. Data dari institusi yang terakreditasi JCI seperti Rumah Sakit Kanker Fuda menunjukkan bahwa mereka sering menggabungkan obat-obatan ini dengan krioterapi. Pendekatan multimodal ini telah digunakan oleh lebih dari 30.000 pasien di seluruh dunia. Paket klinis untuk radioterapi canggih, seperti CyberKnife di Rumah Sakit Jinshazhou, dapat menelan biaya sekitar 56.000 yuan (sekitar $7.750). Pilihan lokal ini seringkali memberikan akses yang lebih cepat daripada menunggu slot dalam uji klinis internasional di kota-kota besar.
Opini pasien: Pasien menekankan pentingnya pengujian MSI dan PD-L1 sedini mungkin untuk mengidentifikasi pilihan pengobatan. Banyak yang mencatat bahwa fruquintinib adalah obat lini ketiga yang efektif dan lebih terjangkau daripada analog impor.
Mengintegrasikan pengobatan tradisional Tiongkok dengan pengobatan Barat untuk kanker kolorektal umumnya aman jika dilakukan di bawah pengawasan profesional. Pusat-pusat pengobatan Tiongkok terkemuka, seperti Rumah Sakit Kanker Fuda, menggunakan protokol komprehensif untuk mengurangi efek samping kemoterapi. Pengobatan terkoordinasi membantu mengelola mual, melindungi fungsi kekebalan tubuh, dan meningkatkan angka harapan hidup lima tahun.
Opini ahli Bookimed: Pasien yang mencari perawatan komprehensif sebaiknya memprioritaskan rumah sakit yang berafiliasi dengan universitas-universitas besar. Misalnya, Rumah Sakit Jinshazhou berafiliasi dengan Universitas Pengobatan Tradisional Tiongkok Guangzhou. Afiliasi ini memastikan bahwa protokol TCM ditinjau oleh dewan onkologi akademis. Paket yang ditawarkan di sana, seperti radioterapi CyberKnife (sekitar $7.850), menekankan presisi teknologi tinggi ala Barat. Ini menegaskan bahwa TCM dipandang sebagai spesialisasi pelengkap, bukan pengganti utama.
Pendapat pasien: Pasien menekankan perlunya menggunakan TCM hanya untuk meredakan gejala setelah ramuan tertentu disetujui oleh dokter onkologi Barat mereka. Banyak yang mencatat bahwa pengujian darah yang ketat sangat penting untuk deteksi dini kasus langka stres ginjal yang disebabkan oleh ramuan herbal.
Chinese medical centres provide recent surgical techniques for rectal cancer. These include robotic-assisted surgery and laparoscopic mesorectal excision. Specialists use the Da Vinci Robotic System and CyberKnife M6 for precision. These methods aim to preserve nerves and speed up recovery times.
Bookimed Expert Insight: Chinese oncology centres blend traditional surgical resection with non-drug therapies. Fuda Cancer Hospital offers over 10 minimally invasive alternatives, such as NanoKnife and cryosurgery. This variety allows for personalised plans, especially for patients with late-stage rectal cancer.
Patient Consensus: Patients value remote video consultations with specialists like Dr Zhang Yanjun before travelling to China. This early access helps clarify the surgical approach. It also confirms details like clinic transfers or medication beforehand.
China offers several innovative, non-surgical treatments for rectal cancer focused on organ preservation. Patients access techniques like NanoKnife, CyberKnife M6, and immunotherapy. These methods target tumours precisely while sparing healthy tissue. Many centres combine Western medicine with traditional Chinese approaches.
Bookimed Expert Insight: While many global centres focus on surgery, Chinese hospitals like Fuda Cancer Hospital specialise in treating over 30,000 international patients. They use minimally invasive local ablation. Their NanoKnife technology is particularly useful for rectal cases where maintaining bowel function is the primary goal.
Active surveillance is an emerging but secondary strategy for rectal cancer in China. It is reserved for patients showing a complete clinical response after chemoradiotherapy. While expert guidelines exist, surgical resection remains the national standard. Major academic centres currently lead its application.
Bookimed Expert Insight: Chinese oncology has shifted towards organ preservation for low rectal tumours. Highly decorated specialists, such as Professor Liu Shi Xin, use VMAT and SBRT technologies. These precise radiation methods aim to achieve the complete response needed for surveillance. Choosing a doctor with high-level academic credentials improves the chance of avoiding major surgery.
Patient Consensus: Patients note that watching and waiting requires a massive long-term commitment to check-ups. Many suggest confirming if Australian specialists can coordinate the intense MRI and endoscopy schedule after returning home.
China uses traditional Chinese medicine (TCM) as an integrative therapy for rectal cancer. It works alongside surgery, chemotherapy, and radiotherapy to manage side effects. Major oncology centres combine these herbs with modern medicine to improve patient immunity and quality of life.
Bookimed Expert Insight: Clinical data shows that Chinese oncology centres specialise in late-stage cases using combined protocols. For example, Jinshazhou Hospital offers CyberKnife M6 radiosurgery alongside traditional medicine expertise. This provides a non-invasive option for patients who want the biological support TCM offers. Dr Zhang Yanjun at this facility holds national radiotherapy committee positions. This helps traditional support meet strict modern standards.
Patient Consensus: Patients in China say that traditional medicine is a supportive tool for wellbeing. It is not used as a primary cure. Clinical focus remains on finding experienced surgeons and precision technologies like NanoKnife for rectal tumours.
Major cancer hospitals in China provide English-speaking doctors and dedicated international departments to support overseas patients. Facilities in cities like Guangzhou and Xiamen offer multilingual services and JCI-accredited care. These centres provide professional medical documentation in English. Specialists often hold degrees and memberships from international organisations.
Bookimed Expert Insight: Many specialists hold international qualifications, but English fluency varies across the full hospital team. Bookimed data shows that packages at Jinshazhou Hospital often include video or text consultations. This allows Australian patients to check the doctor's communication style before travelling for complex surgery.
Patient Consensus: Doctors in major cities often speak English. However, navigating nursing and billing usually requires a dedicated interpreter. Patients should bring written English summaries of prior treatments. This helps all team members understand the medical history during the stay in China.
Choosing the right rectal cancer specialist in China requires selecting leaders at JCI-accredited facilities with high surgical volumes. Australians should focus on professors who lead national oncology boards. These experts use robotic-assisted surgery and precision radiotherapy to improve outcomes and preserve function.
Bookimed Expert Insight: China's top oncology centres often provide unique technologies not widely available elsewhere. These include NanoKnife for irreversible electroporation. For Australian patients, choosing a specialist like Dr Zhang Yanjun at a university-affiliated hospital ensures access to these niche therapies. These hospitals often provide video consultations to review scans before you fly to Guangzhou or Xiamen.
Patient Consensus: Patients note it is important to confirm the team includes surgical, medical, and radiation oncologists. They also suggest arranging English-language records and Australian follow-up care before starting treatment in China.